IBRX is currently covered by 6 analysts with an average price target of $12.92. This is a potential upside of $6.94 (116.05%) from yesterday's end of day stock price of $5.98.
Immunitybio's activity chart (see below) currently has 58 price targets and 90 ratings on display. The stock rating distribution of IBRX is 100% BUY.
Analysts' price targets on this stock were met 69.9% of the time, taking 328.39 days on average.
Highest price target for IBRX is $23, Lowest price target is $7, average price target is $12.92.
Most recent stock forecast was given by KELLY SHI from JEFFERIES on 15-Oct-2026. First documented stock forecast 24-Aug-2015.
Currently out of the existing stock ratings of IBRX, 29 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Aug-2022
$14
$7.98 (132.56%)
$9
1 months 2 days ago
(15-Oct-2026)
2/3 (66.67%)
$4 (40.00%)
354
Buy Since 13-Mar-2025
$15
$8.98 (149.17%)
$15
5 months 15 days ago
(02-Jun-2026)
9/14 (64.29%)
$7.77 (107.47%)
198
Buy Since 12-Mar-2026
$12
$5.98 (99.34%)
$13
5 months 27 days ago
(21-May-2026)
0/3 (0%)
$4.26 (55.04%)
Buy Since 23-Oct-2024
$23
$16.98 (282.06%)
$23
6 months 12 days ago
(05-May-2026)
0/18 (0%)
$15.42 (203.43%)
Buy Since 20-Jan-2026
$12
$5.98 (99.34%)
$7
8 months 13 days ago
(04-Mar-2026)
2/3 (66.67%)
$3 (33.33%)
122
What is IBRX (Immunitybio) average time for price targets to be met?
Which analyst most recently updated their price target on IBRX (Immunitybio)?
Which analyst has the most public recommendations on IBRX (Immunitybio)?
Which analyst is the currently most bullish on IBRX (Immunitybio)?
Which analyst is the currently most reserved on IBRX (Immunitybio)?